Annual EBITDA
-$27.99 M
+$4.77 M+14.56%
December 31, 2023
Summary
- As of February 7, 2025, DRTS annual EBITDA is -$27.99 million, with the most recent change of +$4.77 million (+14.56%) on December 31, 2023.
- During the last 3 years, DRTS annual EBITDA has fallen by -$18.83 million (-205.66%).
- DRTS annual EBITDA is now -252.37% below its all-time high of -$7.94 million, reached on December 31, 2019.
Performance
DRTS EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$8.29 M
+$764.00 K+8.44%
September 30, 2024
Summary
- As of February 7, 2025, DRTS quarterly EBITDA is -$8.29 million, with the most recent change of +$764.00 thousand (+8.44%) on September 30, 2024.
- Over the past year, DRTS quarterly EBITDA has dropped by -$4.96 million (-149.02%).
- DRTS quarterly EBITDA is now -222.44% below its all-time high of -$2.57 million, reached on March 31, 2021.
Performance
DRTS Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$29.10 M
+$635.00 K+2.14%
September 30, 2024
Summary
- As of February 7, 2025, DRTS TTM EBITDA is -$29.10 million, with the most recent change of +$635.00 thousand (+2.14%) on September 30, 2024.
- Over the past year, DRTS TTM EBITDA has dropped by -$31.00 thousand (-0.11%).
- DRTS TTM EBITDA is now -1031.74% below its all-time high of -$2.57 million, reached on March 31, 2021.
Performance
DRTS TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
DRTS EBITDA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +14.6% | -149.0% | -0.1% |
3 y3 years | -205.7% | +52.4% | -8.1% |
5 y5 years | -252.4% | +52.4% | -8.1% |
DRTS EBITDA Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -5.7% | +14.6% | -149.0% | +52.4% | -8.1% | +29.2% |
5 y | 5-year | -252.4% | +14.6% | -222.4% | +52.4% | -1031.7% | +29.2% |
alltime | all time | -252.4% | +14.6% | -222.4% | +52.4% | -1031.7% | +29.2% |
Alpha Tau Medical EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$8.29 M(-8.4%) | -$29.10 M(-2.1%) |
Jun 2024 | - | -$9.05 M(+7.5%) | -$29.73 M(+3.1%) |
Mar 2024 | - | -$8.42 M(+153.0%) | -$28.85 M(-0.8%) |
Dec 2023 | -$27.99 M(-14.6%) | -$3.33 M(-62.7%) | -$29.07 M(-17.7%) |
Sep 2023 | - | -$8.93 M(+9.3%) | -$35.33 M(+4.6%) |
Jun 2023 | - | -$8.17 M(-5.5%) | -$33.76 M(+1.2%) |
Mar 2023 | - | -$8.64 M(-9.9%) | -$33.36 M(+0.3%) |
Dec 2022 | -$32.76 M | -$9.59 M(+30.3%) | -$33.27 M(-19.0%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2022 | - | -$7.36 M(-5.3%) | -$41.09 M(+10.0%) |
Jun 2022 | - | -$7.77 M(-9.1%) | -$37.37 M(+13.6%) |
Mar 2022 | - | -$8.55 M(-50.9%) | -$32.89 M(+22.2%) |
Dec 2021 | -$26.49 M(+189.2%) | -$17.42 M(+379.3%) | -$26.91 M(+183.5%) |
Sep 2021 | - | -$3.63 M(+10.5%) | -$9.49 M(+62.0%) |
Jun 2021 | - | -$3.29 M(+27.9%) | -$5.86 M(+127.9%) |
Mar 2021 | - | -$2.57 M | -$2.57 M |
Dec 2020 | -$9.16 M(+15.3%) | - | - |
Dec 2019 | -$7.94 M | - | - |
FAQ
- What is Alpha Tau Medical annual EBITDA?
- What is the all time high annual EBITDA for Alpha Tau Medical?
- What is Alpha Tau Medical annual EBITDA year-on-year change?
- What is Alpha Tau Medical quarterly EBITDA?
- What is the all time high quarterly EBITDA for Alpha Tau Medical?
- What is Alpha Tau Medical quarterly EBITDA year-on-year change?
- What is Alpha Tau Medical TTM EBITDA?
- What is the all time high TTM EBITDA for Alpha Tau Medical?
- What is Alpha Tau Medical TTM EBITDA year-on-year change?
What is Alpha Tau Medical annual EBITDA?
The current annual EBITDA of DRTS is -$27.99 M
What is the all time high annual EBITDA for Alpha Tau Medical?
Alpha Tau Medical all-time high annual EBITDA is -$7.94 M
What is Alpha Tau Medical annual EBITDA year-on-year change?
Over the past year, DRTS annual EBITDA has changed by +$4.77 M (+14.56%)
What is Alpha Tau Medical quarterly EBITDA?
The current quarterly EBITDA of DRTS is -$8.29 M
What is the all time high quarterly EBITDA for Alpha Tau Medical?
Alpha Tau Medical all-time high quarterly EBITDA is -$2.57 M
What is Alpha Tau Medical quarterly EBITDA year-on-year change?
Over the past year, DRTS quarterly EBITDA has changed by -$4.96 M (-149.02%)
What is Alpha Tau Medical TTM EBITDA?
The current TTM EBITDA of DRTS is -$29.10 M
What is the all time high TTM EBITDA for Alpha Tau Medical?
Alpha Tau Medical all-time high TTM EBITDA is -$2.57 M
What is Alpha Tau Medical TTM EBITDA year-on-year change?
Over the past year, DRTS TTM EBITDA has changed by -$31.00 K (-0.11%)